Premium
BCL6 gene rearrangements also occur in marginal zone B‐cell lymphoma
Author(s) -
DIERLAMM JUDITH,
PITTALUGA STEFANIA,
STUL MICHEL,
WLODARSKA IWONA,
MICHAUX LUCIENNE,
THOMAS JOSÉ,
VERHOEF GREGOR,
VERHEST ALAIN,
DEPARDIEU CLAUDE,
CASSIMAN JEANJACQUES,
HAGEMEIJER ANNE,
DE WOLFPEETERS CHRISTIANE,
VAN DEN BERGHE HERMAN
Publication year - 1997
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.1997.2703087.x
Subject(s) - bcl6 , biology , comparative genomic hybridization , fluorescence in situ hybridization , lymphoma , gene rearrangement , cytogenetics , trisomy , chromosomal translocation , cancer research , pathogenesis , southern blot , marginal zone , chromosomal rearrangement , gene , genetics , pathology , b cell , karyotype , chromosome , immunology , medicine , germinal center , antibody
Marginal zone B‐cell lymphoma (MZBCL) represents a distinct subtype of B‐cell non‐Hodgkin's lymphoma (NHL) which has been recently recognized and defined as a disease entity. Cytogenetically, these lymphomas reveal a high prevalence of trisomy 3, and recent data obtained by comparative genomic hybridization indicate that the chromosomal regions 3q21‐23 and 3q25‐29 might be of particular pathogenetic significance. We identified structural chromosomal abnormalities involving the region 3q27 and rearrangements of the BCL6 proto‐oncogene in three out of 34 (9%) well‐defined cases of extranodal, nodal and splenic MZBCL using cytogenetic analysis, Southern blot, and fluorescence in situ hybridization (FISH). All three cases were characterized by a t(3;14)(q27;q32). Two of them showed additional chromosomal abnormalities including trisomy 3, which was found in one case. The patients displayed extranodal disease and did not demonstrate any striking clinical and histological differences when compared with MZBCL lacking BCL6 rearrangement. The present study for the first time demonstrates the occurrence of t(3;14)/ BCL6 gene rearrangement in MZBCL, thus suggesting a role of the BCL6 proto‐oncogene in the pathogenesis of MZBCL.